The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of ...

Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests.

SAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...

SAN FRANCISCO -- At least 400 researchers, physicians, activists, and other concerned citizens gathered here Monday night to ...

An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.

Prominent gaps in pediatric and adolescent HIV care translate into priorities that need to be addressed for optimizing care ...

Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...

An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...

A NEW injection that could prevent HIV infection has successfully completed an early safety trial, according to a report in ...